1. Home
  2. ENS vs RYTM Comparison

ENS vs RYTM Comparison

Compare ENS & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EnerSys

ENS

EnerSys

HOLD

Current Price

$180.07

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$102.45

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENS
RYTM
Founded
1991
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.4B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
ENS
RYTM
Price
$180.07
$102.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
$175.00
$129.92
AVG Volume (30 Days)
366.3K
616.7K
Earning Date
02-04-2026
02-25-2026
Dividend Yield
0.58%
N/A
EPS Growth
21.73
N/A
EPS
8.58
N/A
Revenue
$3,725,304,000.00
$174,334,000.00
Revenue This Year
$4.38
$47.78
Revenue Next Year
$2.83
$56.52
P/E Ratio
$20.96
N/A
Revenue Growth
6.17
54.92
52 Week Low
$76.57
$45.91
52 Week High
$179.91
$122.20

Technical Indicators

Market Signals
Indicator
ENS
RYTM
Relative Strength Index (RSI) 77.24 45.92
Support Level $172.40 $101.47
Resistance Level $177.47 $109.02
Average True Range (ATR) 4.61 5.38
MACD 1.16 -0.11
Stochastic Oscillator 93.79 35.11

Price Performance

Historical Comparison
ENS
RYTM

About ENS EnerSys

EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Share on Social Networks: